Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke

Nature Medicine

Volumn 15, Issue 2, 2009, Pages 192-199

  Liesz, Arthur ^a   Suri Payer, Elisabeth ^b   Veltkamp, Claudia ^a   Doerr, Henrike ^c   Sommer, Clemens ^c   Rivest, Serge ^d   Giese, Thomas ^a   Veltkamp, Roland ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; BRAIN TUMOR; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; LEUKOCYTE; MALE; MICROGLIA; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION;

ANIMALS; BRAIN; CYTOKINES; CYTOPROTECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROKE; T-LYMPHOCYTES, REGULATORY;

MUS;

EID: 59649123881     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.1927     Document Type: Article

References (50)

1. Donnan, G.A., Fisher, M., Macleod, M. & Davis, S.M. Stroke. Lancet 371, 1612-1623 (2008).
2. Lo, E.H., Dalkara, T. & Moskowitz, M.A. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399-415 (2003).
3. Dirnagl, U. Inflammation in stroke: the good, the bad, and the unknown. Ernst Schering Res. Found. Workshop. 47, 87-99 (2004).
4. Wang, Q., Tang, X.N. & Yenari, M.A. The inflammatory response in stroke. J. Neuroimmunol. 184, 53-68 (2007).
5. Arumugam, T.V., Granger, D.N. & Mattson, M.P. Stroke and T cells. Neuromolecular Med. 7, 229-242 (2005).
6. Perera, M.N. et al. Inflammation following stroke. J. Clin. Neurosci. 13, 1-8 (2006).
7. Meisel, C., Schwab, J.M., Prass, K., Meisel, A. & Dirnagl, U. Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 6, 775-786 (2005).
8. Gee, J.M., Kalil, A., Shea, C. & Becker, K.J. Lymphocytes: potential mediators of postischemic injury and neuroprotection. Stroke 38, 783-788 (2007).
9. + regulatory cells within the central nervous system. J. Immunol. 175, 3025-3032 (2005).
10. Suri-Payer, E. & Fritzsching, B. Regulatory T cells in experimental autoimmune disease. Springer Semin. Immunopathol. 28, 3-16 (2006).
11. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8-27 (2006).
12. + regulatory T cells in the control of experimental CNS autoimmune disease. J. Neuroimmunol. 193, 1-11 (2008).
13. O'Garra, A. & Vieira, P. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10, 801-805 (2004).
14. + regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9, 239-244 (2008).
15. Spera, P.A., Ellison, J.A., Feuerstein, G.Z. & Barone, F.C. IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 251, 189-192 (1998).
16. Gee, J.M., Kalil, A., Thullbery, M. & Becker, K.J. Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke. Stroke 39, 1575-1582 (2008).
17. Offner, H. et al. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J. Immunol. 176, 6523-6531 (2006).
18. McNeill, A., Spittle, E. & Backstrom, B.T. Partial depletion of CD69-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61. Scand. J. Immunol. 65, 63-69 (2007).
19. Schallert, T., Fleming, S.M., Leasure, J.L., Tillerson, J.L. & Bland, S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39, 777-787 (2000).
20. Zhang, L. et al. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J. Neurosci. Methods 117, 207-214 (2002).
21. Barone, F.C. et al. Tumor necrosis factor-α. A mediator of focal ischemic brain injury. Stroke 28, 1233-1244 (1997).
22. Yilmaz, G., Arumugam, T.V., Stokes, K.Y. & Granger, D.N. Role of T lymphocytes and interferon-γ in ischemic stroke. Circulation 113, 2105-2112 (2006).
23. Lambertsen, K.L. et al. A role for interferon-γ in focal cerebral ischemia in mice. J. Neuropathol. Exp. Neurol. 63, 942-955 (2004).
24. Lambertsen, K.L., Meldgaard, M., Ladeby, R. & Finsen, B. A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 25, 119-135 (2005).
25. Rothwell, N.J. & Luheshi, G.N. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23, 618-625 (2000).
26. Gregersen, R., Lambertsen, K. & Finsen, B. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 20, 53-65 (2000).
27. Ito, D., Tanaka, K., Suzuki, S., Dembo, T. & Fukuuchi, Y. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 32, 1208-1215 (2001).
28. Offner, H. et al. Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 26, 654-665 (2006).
29. Grilli, M. et al. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur. J. Neurosci. 12, 2265-2272 (2000).
30. del Zoppo, G.J., Becker, K.J. & Hallenbeck, J.M. Inflammation after stroke: is it harmful? Arch. Neurol. 58, 669-672 (2001).
31. Dirnagl, U., Iadecola, C. & Moskowitz, M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397 (1999).
32. del Zoppo, G. et al. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol. 10, 95-112 (2000).
33. Chamorro, A., Urra, X. & Planas, A.M. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 38, 1097-1103 (2007).
34. Prass, K. et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 198, 725-736 (2003).
35. Planas, A.M., Gorina, R. & Chamorro, A. Signalling pathways mediating inflammatory responses in brain ischaemia. Biochem. Soc. Trans. 34, 1267-1270 (2006).
36. Hurn, P.D. et al. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J. Cereb. Blood Flow Metab. 27, 1798-1805 (2007).
37. Schroeter, M. & Jander, S. T-cell cytokines in injury-induced neural damage and repair. Neuromolecular Med. 7, 183-195 (2005).
38. Wajant, H., Pfizenmaier, K. & Scheurich, P. Tumor necrosis factor signaling. Cell Death Differ. 10, 45-65 (2003).
39. Baird, A.E. The forgotten lymphocyte: immunity and stroke. Circulation 113, 2035-2036 (2006).
40. Campanella, M., Sciorati, C., Tarozzo, G. & Beltramo, M. Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke 33, 586-592 (2002).
41. + regulatory T cells in the steady state. J. Exp. Med. 198, 737-746 (2003).
42. + T cells following ischemic stroke. J. Neurol. Sci. 233, 125-132 (2005).
43. Strle, K. et al. Interleukin-10 in the brain. Crit. Rev. Immunol. 21, 427-449 (2001).
44. Vignali, D.A., Collison, L.W. & Workman, C.J. How regulatory T cells work. Nat. Rev. Immunol. 8, 523-532 (2008).
45. + Tregs: limiting collateral damage. J. Clin. Invest. 114, 1372-1378 (2004).
46. Vogel, J., Mobius, C. & Kuschinsky, W. Early delineation of ischemic tissue in rat brain cryosections by high-contrast staining. Stroke 30, 1134-1141 (1999).
47. Schallert, T., Hernandez, T.D. & Barth, T.M. Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res. 379, 104-111 (1986).
48. Steiner, G.E., Ecker, R.C., Kramer, G., Stockenhuber, F. & Marberger, M.J. Automated data acquisition by confocal laser scanning microscopy and image analysis of triple stained immunofluorescent leukocytes in tissue. J. Immunol. Methods 237, 39-50 (2000).
49. Blais, V. & Rivest, S. Effects of TNF-α and IFN-γ on nitric oxide-induced neurotoxicity in the mouse brain. J. Immunol. 172, 7043-7052 (2004).
50. Nadeau, S. & Rivest, S. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor κ B activity in the brain during endotoxemia. J. Neurosci. 20, 3456-3468 (2000).